RSS

real-world data

The use of real-world data is key if medicines are to be made safer for patients, delegates at the Drug Safety Research Unit’s (DSRU) international pharmacovigilance conference heard last month. Read more

News

In this online exclusive, Mike Novotny of Medrio, looks at the rise of real-world data as a result of patient centric approaches and movement towards precision medicine, and how new tech may help with collection and analysis. Read more

Opinion

In this online exclusive, Dr Andrew Rut, CEO of MyMeds&Me, discusses the value of big data for the pharma industry and the conflict that arises between protecting personal data and effective drug development Read more

Opinion

According to data and analytics company, GlobalData, new real-world evidence will support the use of a biosimilar treatment for Crohn’s disease (CD), leading to a boost in the biosimilar market value. Read more

Analysis

Real world evidence from a study involving almost 30,000 people, supporting the benefits of long-acting antipsychotics (LATs) in reducing the risk of mortality among schizophrenic patients, has been announced by Janssen Pharmaceutical Read more

News

Real-world data presented by Merck have demonstrated the long-term clinical effectiveness of golimumab (Simponi) for the treatment of rheumatic diseases. Read more

News

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a response to the recently published study in the British Medical Journal (BMJ) on the efficacy of cancer medicines, noting the importance of real-world data. Read more

Opinion

The US Food and Drug Administration (FDA) has granted an award to clinical research infrastructure provider, Elligo Health Research to evaluate a harmonised data model that will help in the safety assessment of new oncology therapies. Read more

News